Normunity

Series-B+
normunity.com Biotech & Healthcare New Haven, United States Founded 2021 11-50
Total Funding $140M
Latest Round $75M Series-B+
Last Announced Jan 13, 2025
Investors 12 Backers
Decision Makers 6 Verified

About Normunity

Normunity develops novel anti-cancer therapies, including therapeutic antibodies, bispecific antibodies, and payload-carrying biologics. These medicines target mechanisms at the interface of the immune system and tumors to impact tumor growth and circumvent immune surveillance. Normunity's customers are cancer patients, and it makes money by developing and advancing a pipeline of biologic medicines.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters New Haven, United States
Year Founded 2021
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website normunity.com
Domain Registered Date May 8, 2020

Social & Network Presence

X / Twitter Profile @normunity (34 followers) Created on Oct 2022
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $75,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Raised $65,000,000 · Series-A

    startupintros.com

  3. Milestone

    X account created (@normunity)

    34 followers

  4. Milestone

    Company founded

    New Haven, United States

  5. Milestone

    Website domain registered

    normunity.com

Investors & Backers

12
Canaan Partners
Connecticut Innovations
Enavate Sciences
HSG
Osage Venture Partners
OUP (Osage University Partners)
Pfizer Venture Investments
Regeneron Ventures
Samsara Biocapital
Sanofi Ventures
Taiho Ventures
YK Bioventures

Funding History

2 Rounds
Series-B+ · Jan 13, 2025
Series-A · Oct 25, 2022

Founders & Leadership

6

Ellen Forest

Interim Head of Human Resources

Work email & phone locked Unlock →

Kristin Robbins

VP, Program & Portfolio Management

Work email & phone locked Unlock →

Melinda Merchant

Chief Medical Officer

Work email & phone locked Unlock →

Olga Granaturova

Chief Operating Officer and Chief Business Officer

Work email & phone locked Unlock →

Rachel W. Humphrey

Founder

Work email & phone locked Unlock →

William LaRochelle

Chief Scientific Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts